Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 20 10 2018
medline: 5 6 2020
entrez: 20 10 2018
Statut: ppublish

Résumé

The aim of this study was to evaluate trends over time in perioperative outcomes for patients undergoing hepatectomy. As perioperative care and surgical technique for hepatectomy have improved, the indications for and complexity of liver resections have evolved. However, the resulting effect on the short-term outcomes over time has not been well described. Consecutive patients undergoing hepatectomy during 1998 to 2015 at 1 institution were analyzed. Perioperative outcomes, including the comprehensive complication index (CCI), were compared between patients who underwent hepatectomy in the eras 1998 to 2003, 2004 to 2009, and 2010 to 2015. The study included 3707 hepatic resections. The number of hepatectomies increased in each era (794 in 1998 to 2003, 1402 in 2004 to 2009, and 1511 in 2010 to 2015). Technical complexity increased over time as evidenced by increases in the rates of major hepatectomy (20%, 23%, 30%, P < 0.0001), 2-stage hepatectomy (0%, 3%, 4%, P < 0.001), need for portal vein embolization (5%, 9%, 9%, P = 0.001), preoperative chemotherapy for colorectal liver metastases (70%, 82%, 89%, P < 0.001) and median operative time (180, 175, 225 minutes, P < 0.001). Significant decreases over time were observed in median blood loss (300, 250, 200 mL, P < 0.001), transfusion rate (19%, 15%, 5%, P < 0.001), median length of hospitalization (7, 7, 6 days, P < 0.001), rates of CCI ≥26.2 (20%, 22%, 16%, P < 0.001) and 90-day mortality (3.1%, 2.6%, 1.3%, P < 0.01). On multivariable analysis, hepatectomy in the most recent era 2010 to 2015 was associated with a lower incidence of CCI ≥26.2 (odds ratio 0.7, 95% confidence interval 0.6-0.8, P < 0.0001). Despite increases in complexity over an 18-year period, continued improvements in surgical technique and perioperative outcomes yielded a resultant decrease in CCI in the most current era.

Sections du résumé

OBJECTIVE
The aim of this study was to evaluate trends over time in perioperative outcomes for patients undergoing hepatectomy.
BACKGROUND
As perioperative care and surgical technique for hepatectomy have improved, the indications for and complexity of liver resections have evolved. However, the resulting effect on the short-term outcomes over time has not been well described.
METHODS
Consecutive patients undergoing hepatectomy during 1998 to 2015 at 1 institution were analyzed. Perioperative outcomes, including the comprehensive complication index (CCI), were compared between patients who underwent hepatectomy in the eras 1998 to 2003, 2004 to 2009, and 2010 to 2015.
RESULTS
The study included 3707 hepatic resections. The number of hepatectomies increased in each era (794 in 1998 to 2003, 1402 in 2004 to 2009, and 1511 in 2010 to 2015). Technical complexity increased over time as evidenced by increases in the rates of major hepatectomy (20%, 23%, 30%, P < 0.0001), 2-stage hepatectomy (0%, 3%, 4%, P < 0.001), need for portal vein embolization (5%, 9%, 9%, P = 0.001), preoperative chemotherapy for colorectal liver metastases (70%, 82%, 89%, P < 0.001) and median operative time (180, 175, 225 minutes, P < 0.001). Significant decreases over time were observed in median blood loss (300, 250, 200 mL, P < 0.001), transfusion rate (19%, 15%, 5%, P < 0.001), median length of hospitalization (7, 7, 6 days, P < 0.001), rates of CCI ≥26.2 (20%, 22%, 16%, P < 0.001) and 90-day mortality (3.1%, 2.6%, 1.3%, P < 0.01). On multivariable analysis, hepatectomy in the most recent era 2010 to 2015 was associated with a lower incidence of CCI ≥26.2 (odds ratio 0.7, 95% confidence interval 0.6-0.8, P < 0.0001).
CONCLUSION
Despite increases in complexity over an 18-year period, continued improvements in surgical technique and perioperative outcomes yielded a resultant decrease in CCI in the most current era.

Identifiants

pubmed: 30339628
doi: 10.1097/SLA.0000000000003043
pmc: PMC6864233
mid: NIHMS1058888
pii: 00000658-202004000-00021
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

724-731

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009599
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

J Am Coll Surg. 2007 May;204(5):854-62; discussion 862-4
pubmed: 17481498
JAMA Surg. 2017 Oct 18;152(10):e172986
pubmed: 28854316
Ann Surg. 2003 Feb;237(2):208-17
pubmed: 12560779
Arch Surg. 2003 Nov;138(11):1198-206; discussion 1206
pubmed: 14609867
J Hepatol. 2017 Jul;67(1):56-64
pubmed: 28192187
J Am Coll Surg. 1999 Mar;188(3):304-9
pubmed: 10065820
JAMA. 2009 Dec 2;302(21):2338-44
pubmed: 19952320
J Am Coll Surg. 2001 Jul;193(1):109-11
pubmed: 11442247
J Am Coll Surg. 2013 Feb;216(2):201-9
pubmed: 23219349
J Am Coll Surg. 2015 Dec;221(6):1023-30.e1-2
pubmed: 26611799
J Gastrointest Surg. 2018 Jan;22(1):60-67
pubmed: 28585106
J Am Coll Surg. 2013 Dec;217(6):1028-37
pubmed: 24246619
Ann Surg. 2016 Jan;263(1):146-52
pubmed: 25775068
World J Surg. 1993 Mar-Apr;17(2):250-5
pubmed: 8511922
Ann Surg. 2009 Jun;249(6):995-1002
pubmed: 19474679
Ann Surg. 2013 Oct;258(4):619-26; discussion 626-7
pubmed: 24018645
Surgery. 2011 May;149(5):680-8
pubmed: 21316725
Surgery. 2000 May;127(5):512-9
pubmed: 10819059
HPB (Oxford). 2013 Nov;15(11):908-15
pubmed: 23461811
Surgery. 2016 Mar;159(3):793-801
pubmed: 26584854
Arch Surg. 2002 Mar;137(3):311-5
pubmed: 11888456
J Clin Oncol. 2011 Mar 10;29(8):1083-90
pubmed: 21263087
Hepatology. 1997 Nov;26(5):1176-81
pubmed: 9362359
J Gastrointest Surg. 2017 Jan;21(1):85-93
pubmed: 27496092
J Gastrointest Surg. 2017 Apr;21(4):628-635
pubmed: 27882510
J Am Coll Surg. 2007 Jun;204(6):1284-92
pubmed: 17544086
Ann Surg Oncol. 2013 Aug;20(8):2493-500
pubmed: 23377564
Ann Surg. 1908 Oct;48(4):541-9
pubmed: 17862242
Surgery. 2000 Feb;127(2):155-60
pubmed: 10686980
Ann Surg. 2005 Aug;242(2):172-7
pubmed: 16041206
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
Ann Surg. 2015 Dec;262(6):1071-8
pubmed: 25590497
Ann Surg. 2004 May;239(5):722-30; discussion 730-2
pubmed: 15082977
Surgery. 1996 May;119(5):498-504
pubmed: 8619203
HPB (Oxford). 2018 Jul;20(7):591-596
pubmed: 29331277
J Clin Oncol. 2012 Dec 20;30(36):4566-72
pubmed: 23150701
Ann Surg. 2009 Oct;250(4):540-8
pubmed: 19730239
J Am Coll Surg. 2015 Jul;221(1):38-46
pubmed: 26047760
Ann Surg. 2017 Dec;266(6):1045-1054
pubmed: 27735824
HPB (Oxford). 2009 Sep;11(6):510-5
pubmed: 19816616
J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):215-25
pubmed: 15713922
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Br J Surg. 2007 Mar;94(3):274-86
pubmed: 17315288
J Am Coll Surg. 2015 Apr;220(4):471-9
pubmed: 25667141
J Am Coll Surg. 2016 Jul;223(1):99-108
pubmed: 26968325
Surgery. 2010 Jan;147(1):40-8
pubmed: 19733879
Ann Surg Oncol. 2017 Apr;24(4):1046-1047
pubmed: 27995453
Surgery. 2008 Nov;144(5):744-51
pubmed: 19081016
Liver Transpl. 2002 Mar;8(3):233-40
pubmed: 11910568
Ann Surg Oncol. 2013 Jan;20(1):139-47
pubmed: 22825774
J Gastrointest Surg. 2013 Jan;17(1):57-64; discussion p.64-5
pubmed: 22956403
Ann Surg. 2013 Jul;258(1):129-40
pubmed: 23059502
J Am Coll Surg. 1998 Dec;187(6):620-5
pubmed: 9849736
Arch Surg. 2010 Mar;145(3):281-4
pubmed: 20231630

Auteurs

Jordan M Cloyd (JM)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Takashi Mizuno (T)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Yoshikuni Kawaguchi (Y)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Heather A Lillemoe (HA)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Georgios Karagkounis (G)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Kiyohiko Omichi (K)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Yun Shin Chun (YS)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Claudius Conrad (C)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Ching-Wei D Tzeng (CD)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Bruno C Odisio (BC)

Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Steven Y Huang (SY)

Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Marshall Hicks (M)

Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Steven H Wei (SH)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Thomas A Aloia (TA)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jean-Nicolas Vauthey (JN)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH